Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04925479
Title Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | NLD | ITA | FRA | DEU

Facility Status City State Zip Country Details
Dana Farber Cancer Institute Dept.of DFCI RECRUITING Boston Massachusetts 02215 United States Details
Columbia University Medical Center- New York Presbyterian Herbert Irving Cancer Center RECRUITING New York New York 10032 United States Details
Cinn Children Hosp Medical Center RECRUITING Cincinnati Ohio 45229-3039 United States Details
University of Utah Primary Childrens Hospital RECRUITING Salt Lake City Utah 84132 United States Details
Novartis Investigative Site RECRUITING Tianjin Tianjin 300020 China Details
Novartis Investigative Site RECRUITING Hangzhou Zhejiang 310005 China Details
Novartis Investigative Site RECRUITING Beijing 100044 China Details
Novartis Investigative Site RECRUITING Shanghai 200127 China Details
Novartis Investigative Site RECRUITING Bordeaux Cedex 33076 France Details
Novartis Investigative Site RECRUITING Lille 59000 France Details
Novartis Investigative Site RECRUITING Paris 75019 France Details
Novartis Investigative Site RECRUITING Poitiers 86021 France Details
Novartis Investigative Site RECRUITING Erlangen 91054 Germany Details
Novartis Investigative Site RECRUITING Essen 45147 Germany Details
Novartis Investigative Site RECRUITING Hamburg 20246 Germany Details
Novartis Investigative Site RECRUITING Athens 115 27 Greece Details
Novartis Investigative Site RECRUITING Budapest 1094 Hungary Details
Novartis Investigative Site RECRUITING Genova GE 16147 Italy Details
Novartis Investigative Site RECRUITING Monza MB 20900 Italy Details
Novartis Investigative Site RECRUITING Yokohama-city Kanagawa 232-8555 Japan Details
Novartis Investigative Site RECRUITING Shinjuku-ku Tokyo 160 8582 Japan Details
Novartis Investigative Site RECRUITING Osaka 534-0021 Japan Details
Novartis Investigative Site RECRUITING Seoul Korea 05505 Korea, Republic of Details
Novartis Investigative Site RECRUITING Seoul 03080 Korea, Republic of Details
Novartis Investigative Site RECRUITING Utrecht CS 3584 Netherlands Details
Novartis Investigative Site RECRUITING Wrocław 50367 Poland Details
Novartis Investigative Site RECRUITING Moscow 117198 Russian Federation Details
Novartis Investigative Site RECRUITING Saint Petersburg 197022 Russian Federation Details
Novartis Investigative Site RECRUITING Muang Chiangmai 50200 Thailand Details
Novartis Investigative Site RECRUITING Bangkok 10400 Thailand Details
Novartis Investigative Site RECRUITING Khon Kaen 40000 Thailand Details
Novartis Investigative Site RECRUITING Bursa Gorukle 16059 Turkey Details
Novartis Investigative Site RECRUITING Istanbul 34093 Turkey Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field